Gupta, Ravindra K.Gregson, John.Parkin, Neil.Haile-Selassie, Hiwot.Tanuri, Amilcar.Andrade Forero, Liliana.Kaleebu, Pontiano.Watera, Christine.Aghokeng, Avelin.Mutenda, Nicholus.Dzangare, Janet.Hone, San.Hang, Zaw Zaw.Garcia, Judith.Garcia, Judith.Garcia, Zully.Marchorro, Paola.Beteta, Enrique.Giron, Amalia.Hamers, Raph.Inzaule, Seth.Frenkel, Lisa M.Chung, Michael H.De Oliveira, Tulio De Paiva Nazareth Andrade.Pillay, Deenan.Naidoo, Kogieleum.Kharsany, Ayesha Bibi Mahomed.Kugathasan, Ruthiran.Cutino, Teresa.Hunt, Gillian.Avila Rios, Santiago.Doherty, Meg.Jordan, Michael R.Bertagnolio, Silvia.2019-12-152019-12-1520182018Gupta, R.K., Gregson, J., Parkin, N., Haile-Selassie, H., Tanuri, A., Forero, L.A., Kaleebu, P., Watera, C., Aghokeng, A., Mutenda, N., Dzangare, J., Hone, S., Hang, Z.Z., Garcia, J., Garcia, Z., Marchorro, P., Beteta, E., Giron, A., Hamers, R., Inzaule, S., Frenkel, L.M., Chung, M.H., de Oliveira, T., Pillay, D., Naidoo, K., Kharsany, A., Kugathasan, R., Cutino, T., Hunt, G., Avila Rios, S., Doherty, M., Jordan, M.R. and Bertagnolio, S. 2018. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. Lancet Infectious Diseases 18(3), 346-355.http://dx.doi.org/10.1016/S1473-3099(17)30702-8https://researchspace.ukzn.ac.za/handle/10413/16646CAPRISA, 2018.Abstract available in pdf.enAnti-HIV Agents/pharmacology.Developing Countries.HIV Infections/epidemiology.HIV Infections/virology.HIV-1/drug effects.Humans.HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.Article